Skip to main content

Table 3 Clinical characteristics of patients with monosomy 3p with different break points and sizes

From: Trisomy 1q41-qter and monosomy 3p26.3-pter in a family with a translocation (1;3): further delineation of the syndromes

Reference

Fernandez [22]

Fernandez [23]

Gunnarson [24]

Shuib [25]

Pohjola [26]

Cuoco [27]

Chen [28]

Peltekova [29]

Our study

3p monosomic segment/ Size

p26a none

p26.2-pterb 4.5 Mb

p25.3-p26.1c 1.6 Mb

p25.2-pter 12.65 Mb, 12.25 Mb, 12.05 Mb

p25.3-pter 9.55 Mb to 11.50 Mb

p25.3-p26.1 6.3 Mb

p26.1-pter 8.6 Mb

p25.3-pter 9.0 Mb

p26.3-pter 1.10 Mb

p26.3-pter 0.90 Mb

p25.3-pter 9.3 Mb

p25.3-p25.3 0.643 Mb

p26.3-pter 1.70 Mb

Cytogenetic analysis

K, FISH, SNPa

K, FISH, aCGH

K, SNPa

K, MLPA, SNPa

K, FISH, SNPa, MLPA, SEQ

K, FISH, SNPa,MLPA

K, aCGH, QF-PCRd

K, FISH, aCGH, Q-PCR

K, FISH HDMA

Number of patients

   

3

9

    

2

   

Origin

de novo

de novo

de novo

de novo

de novo

de novo

de novo

mate

matf

patg

de novo

NR

mat

Gender

M

M

F

NR

NR

NR

NR

M

M

M/M

F

F

M

Age

7y 11 m

5y 6 m

4y

NR

NR

NR

NR

12y

12y

9y/7y

24wg

22y †

2y 8 m

PGD

+

+

-

NR

NR

NR

NR

-

+

0/2

NA

+

+

Hypotonia

+

-

+

NR

NR

NR

NR

+

-

0/2

NA

-

+

Hirsutism

+

-

-

NR

NR

NR

NR

-

-

0/2

NR

-

+

Microcephaly

-

+

+

NR

2/9

+

NR

-

+

0/2

NR

+

-

CNSA

-

-

+

NR

NR

NR

NR

-

-

1/2

-

+

+

Triangular face

-

+

-

NR

NR

NR

NR

-g

-

0/2

NR

+

+

DSPF

+

+

-

NR

NR

NR

NR

-

-

0/2

NR

+

-

Ptosis

+

-

+

NR

2/9

+

NR

-

-

0/2

NR

+

+

Hypertelorism

+

+

+

NR

NR

NR

NR

-

-

0/2

+

-

+

OEA

+

NR

+

NR

NR

NR

NR

-

-

1/2

NR

+

+

Broad nasal bridge

+

+

+

NR

NR

NR

NR

+

-

0/2

NR

+

+

Hypoplasic nostrils

-

+

-

NR

NR

NR

NR

-

-

0/2

NR

-

-

High or cleft palate

-

+

-

NR

NR

NR

NR

+

-

0/2

NR

+

+

Micrognathia

-

+

-

NR

2/9

NR

NR

-

-

0/2

+

-

+

Dysmorphic ears

+

+

+

NR

NR

NR

NR

+

-

0/2

+

+

+

CHD

-

-

+

3/3

2/9

-

-

-

-

0/2

-

+

-

GTA

-

+

-

NR

NR

NR

NR

-

-

0/2

NR

-

-

Limb abnormalities

+

+

+

NR

NR

NR

NR

+

+

0/2

NR

+

+

PD/MR

BL

+

+

3/3

9/9

+

-

LD

LD

BL/-

NA

+

+

Abnormal Language

+

+

+

NR

NR

NR

NR

+

+

2/2

NA

+

+

Seizures

-

+

+

NR

NR

NR

-

-

-

1/2

NA

+

+

  1. a: 46,XY,t(3;10)(p26;q26), disruption of CNTN4; b: 45,XY,der(3)t(3;13)(p26.2;q12.13),-13; c: In vitro fertilization; d: amniocentesis and pregnancy interruption; e: mother and sister with the same deletion; f: mother with the same deletion without clinical data and mildly dysmorphic features; g: father with same deletion and no clinical data; h: asymmetric face; aCGH: array Comparative Genomic Hybridization; BL: BorderLine; DSPF: Down Slating Palpebral Fissures; F: Female; FISH: Fluorescent in situ hybridization; GTA: Genitourinary Track Anomalies; HDMA: high density microarray; K: Karyotype with banding techniques; LD: Learning Disability; M: Male; m: months; NA: Not Applicable; NR: No Reported; SEQ: sequencing of candidate genes; PD/MR: Psychomotor Delay/Mental Retardation; PGD: Postnatal Growth Delay; QF-PCR: Quantitative Fluorescent-PCR; SNPa: Single Nucleotide Polymorphism array; wg: weeks of gestation; y: years; †: dead at the time of report; +: feature present; -: feature absent.